Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 20/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17669284 | 1.00 | FFAR1 (0.64) | FFAR1 | |
| SCHEMBL17386238 | 0.89 | FFAR1 (0.53) | FFAR1 | |
| SCHEMBL17386236 | 0.89 | FFAR1 (0.53) | FFAR1 | |
| SCHEMBL13616548 | 0.82 | FFAR1 (0.91) | FFAR1 | |
| SCHEMBL4652352 | 0.79 | CXCR2 (0.57) | FFAR1 | |
| SCHEMBL22800008 | 0.79 | FFAR1 (0.65) | FFAR1 | |
| SCHEMBL21121318 | 0.79 | FFAR1 (0.65) | FFAR1 | |
| SCHEMBL21121317 | 0.79 | FFAR1 (0.65) | FFAR1 | |
| SCHEMBL30618892 | 0.78 | FFAR1 (1.00) | FFAR1 | |
| SCHEMBL3520418 | 0.78 | FFAR1 (0.81) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11731961-B2 | Phenyl propionic acid derivatives and uses thereof | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| EP-3555076-B1 | NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF | IL DONG PHARMA (KR) | 2023-04-05 | — | — | EP | disclosed |
| US-20220112185-A1 | NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2022-04-14 | — | — | US | disclosed |
| US-20220064154-A1 | NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF | ILDONG PHARMACEUTICAL CO, LTD. (KR) | 2022-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064154-A1 | NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF | GPR119, GPR65, GPR55 | FFAR1 10/4885 |
| US-20220112185-A1 | NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF | GPR119, GPR55, GPR65 | FFAR1 7/4885 |
| US-11731961-B2 | Phenyl propionic acid derivatives and uses thereof | GPR119, GPR65, GPR55 | FFAR1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.